ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

@article{Chey2017ACGCG,
  title={ACG Clinical Guideline: Treatment of Helicobacter pylori Infection},
  author={W. Chey and G. Leontiadis and C. Howden and S. Moss},
  journal={The American Journal of Gastroenterology},
  year={2017},
  volume={112},
  pages={212-239}
}
Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer. [...] Key Method When first-line therapy fails, a salvage regimen should avoid antibiotics that were previously used. If a patient received a first-line treatment containing clarithromycin, bismuth quadruple therapy or levofloxacin salvage regimens are the preferred treatment options.Expand

Paper Mentions

Interventional Clinical Trial
Background: Potent antithrombotic therapy has improved prognosis for patients with acute myocardial infarction (MI) significantly, however, at a price of increased bleeding risk… Expand
ConditionsCardiovascular Diseases, GastroIntestinal Bleeding, Helicobacter Pylori Infection, (+1 more)
InterventionDiagnostic Test
Interventional Clinical Trial
Thrombocytopenia refers to a reduction in platelet count to (<150 × 109/L). Immune thrombocytopenic purpura is an acquired autoimmune disorder defined by isolated… Expand
ConditionsImmune Thrombocytopenia
InterventionDrug
Interventional Clinical Trial
the effect of eradication of H-pylori in pregnant patients with iron deficiency anemia on the level of hemoglobin after iron therapy.  
ConditionsAnemia, Iron Deficiency, H Pylori Infection, Pregnancy Complications
InterventionDrug
Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori
TLDR
It is shown that Levofloxacin based triple antibiotic regimen may not be a good first-line therapy among this US population and the Clarithromycin based regimen may still be used successfully. Expand
Review: Treatment of Helicobacter pylori infection
TLDR
High-dose dual therapy consisting of amoxicillin and a PPI has been proposed as an effective and safe first-line or rescue therapy due to the bacterial resistance to antibiotics that can limit the applicability of such regimens. Expand
Helicobacter pylori Infection: An Update for the Internist in the Age of Increasing Global Antibiotic Resistance.
TLDR
The changing epidemiology of H. pylori is outlined, new treatment options or modifications of established regimens are recommended by updated practice guidelines for primary or secondary therapy are highlighted, and current management options in this era of growing antibacterial resistance are highlighted. Expand
Appropriateness of Helicobacter pylori eradication therapy in gastroenterology patients of a tertiary care hospital
TLDR
Overall therapy was unsatisfactory due to inappropriate dose, duration, or sub-optimal adherence, and the H. pylori eradication regimen containing clarithromycin was more effective in symptom control. Expand
Treatment of Helicobacter pylori in Special Patient Populations
TLDR
The existing evidence for first‐ and second‐line treatment regimens that may be considered for special populations such as patients with penicillin allergies, patients with or at risk for QTc‐interval prolongation, and patients who are pregnant, breastfeeding, or elderly are summarized. Expand
RECENT GUIDELINES FOR H. PYLORI ERADICATION THERAPY
Helicobacter pylori infection is one of the commonest chronic infections worldwide with an estimated 50% of the world’s population being infected. Approximately, 15 to 20% of infected individualsExpand
The status and progress of first-line treatment against Helicobacter pylori infection: a review
  • Caiqi Liu, Yuan Wang, +4 authors T. Zheng
  • Medicine
  • Therapeutic advances in gastroenterology
  • 2021
TLDR
The effectiveness and safety of various emerging treatment regimens for HP, including the modified bismuth-containing quadruple regimen, high-dose dual therapy, and vonoprazan-containing regimens, are summarized. Expand
Sequential Therapy for Helicobacter pylori Eradication with or without Bismuth Subcitrate
Background: Helicobacter pylori (H. pylori) is one of the most common infections worldwide, can lead to several upper gastrointestinal (GI) tract conditions. Recent reports have shown that H. pyloriExpand
Helicobacter Pylori Eradication Therapy: Still a Challenge
TLDR
In this study, levofloxacin-based triple, concomitant, and standard triple regimens with probiotic treatments are maximally acceptable treatments. Expand
Persistent Helicobacter pylori Infection: An Insight to the Limitations of Current Clinical Practice
TLDR
The case of a 64-year-old female who was previously given six treatment courses for persistent H. pylori infection and successful eradication was achieved with rifabutin triple therapy consisting of high-dose amoxicillin and strict adherence monitoring by a clinical pharmacist is detailed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 256 REFERENCES
American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
TLDR
Whether to test for H. pylori in patients with functional dyspepsia, gastroesophageal reflux disease (GERD), patients taking nonsteroidal antiinflammatory drugs, with iron deficiency anemia, or who are at greater risk of developing gastric cancer remains controversial. Expand
Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers
TLDR
Eradication of H pylori before NSAID therapy reduces the occurrence of NSAID-induced peptic ulcers in patients with musculoskeletal pain. Expand
Effect of Helicobacter pylori Eradication in Patients with Chronic Idiopathic Thrombocytopenic Purpura—A Randomized Controlled Trial
TLDR
An ELISA titer of serum anti-CagA antibody may be a good predictor of platelet recovery, and immunological reaction between platelet and anti- CagA antibodies may have some relation to the pathogenesis of H. pylori-positive patients with cITP. Expand
Factors influencing the eradication of Helicobacter pylori with triple therapy.
TLDR
It is concluded that triple therapy is effective for eradication of H. pylori and that future studies need to take compliance into account for comparisons between regimens. Expand
Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.
  • G. Fiorini, N. Vakil, +6 authors D. Vaira
  • Medicine
  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2013
BACKGROUND & AIMS Eradication of Helicobacter pylori using empiric therapy has become difficult as a result of increasing resistance to antibiotics. We evaluated the efficacy of specific treatments,Expand
The Relationship among Previous Antimicrobial Use, Antimicrobial Resistance, and Treatment Outcomes for Helicobacter pylori Infections
TLDR
This retrospective study examined relationships between resistant H. pylori infections and past antibiotic use in 125 Alaskan Native adults to determine reinfection rates after successful eradication of H.pylori infection among Alaska Natives living in Anchorage. Expand
The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use.
  • S. Lim, Rae Woong Park, +6 authors K. Lee
  • Medicine
  • Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2016
TLDR
A patient's history of macrolides is a useful predictor of the likelihood of standard triple therapy failure in H. pylori eradication and the alternatives such as a bismuth-based quadruple or a levofloxacin-containing therapy should be considered in patients treated with macrolide use for >2 weeks. Expand
Helicobacter pylori eradication: Novel therapy for immune thrombocytopenic purpura? A review of the literature
TLDR
Large randomized‐controlled studies enrolling patients from various ethnic backgrounds will be necessary to determine the response rate and mechanism of response and to gain a better understanding of the pathogenesis of ITP. Expand
A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication)
TLDR
The aim of this study is to systematically review the efficacy of the second-line rescue therapies after the failure of a first-line clarithromycin-containing regimen, and to link this information with the previous first- line treatment. Expand
Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.
TLDR
Accumulating evidence indicates that surveillance of antimicrobial resistance by susceptibility testing is feasible and necessary to inform clinicians in their choice of therapy for management of H. pylori infection. Expand
...
1
2
3
4
5
...